Intravenous OxyContin‐associated thrombotic microangiopathy treated successfully without plasma exchange | Zendy

Tate Courtney | Zendy; Mollee Peter | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

Intravenous OxyContin‐associated thrombotic microangiopathy treated successfully without plasma exchange

Author(s) -

Tate Courtney,

Mollee Peter

Publication year - 2015

Publication title -

medical journal of australia

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.904

H-Index - 131

eISSN - 1326-5377

pISSN - 0025-729X

DOI - 10.5694/mja14.01125

Subject(s) - thrombotic microangiopathy , medicine , therapeutic plasma exchange , microangiopathy , endocrinology , diabetes mellitus , disease

A 56-year-old man of European ancestry with no clinically significant medical history presented with a 3-day history of periumbilical abdominal pain. He admitted to daily intravenous (IV) misuse of oral extended-release oxycodone hydrochloride (OxyContin; Mundipharma) over a period of months. For the 5 weeks before presentation, he had been injecting the new tamper-resistant formulation because he was unable to access the discontinued crushable form.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research